Generic · Tablet · Updated Nov 11, 2026
Everolimus 0.5 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for everolimus 0.5 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Everolimus 0.5 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $96.07
- 52-week low
- $96.07
- 52-week high
- $128.99
- A year ago
- $131.99
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $3.52 | $3.20 | -9.2% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $3.76 | $3.52 | -6.2% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $3.73 | $3.76 | +0.8% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $3.69 | $3.73 | +1.0% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $3.60 | $3.69 | +2.3% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $3.74 | $3.60 | -3.6% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $3.97 | $3.74 | -5.8% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $3.94 | $3.97 | +0.6% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for everolimus 0.5 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Everolimus, Tablet, .5 mg (NDC 49884-159-02)A business decision was made to withdraw from sale.
- Everolimus, Tablet, 1 mg (NDC 49884-283-02)A business decision was made to withdraw from sale.
- Everolimus, Tablet, .25 mg (NDC 49884-158-02)A business decision was made to withdraw from sale.
- Everolimus, Tablet, .75 mg (NDC 49884-160-02)A business decision was made to withdraw from sale.
- Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 10 mg (NDC 0093-7769-24)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 5 mg (NDC 0093-7767-24)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 7.5 mg (NDC 49884-127-91)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 10 mg (NDC 49884-128-91)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 5 mg (NDC 49884-125-91)Discontinuation of the manufacture of the drug
- Everolimus, Tablet, 2.5 mg (NDC 49884-119-91)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
6 companies sell everolimus 0.5 mg tablet under 10 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Ascend Laboratories, LLC | 67877-719-31 | $3.20 |
| Aurobindo Pharma Limited | 59651-932-60 | $3.20 |
| Biocon Pharma Inc. | 70377-070-11 | $3.20 |
| Breckenridge Pharmaceutical, Inc. | 51991-380-06 51991-380-60 | $3.20 |
| Hikma Pharmaceuticals USA Inc. | 0054-0471-21 | $3.20 |
| Par Health USA, LLC | 49884-159-02 | $3.20 |
All 10 package codes
3 older package codes are still priced but no longer in the current FDA listing.
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Would 0.25 mg tablet work for me instead?" Pharmacies pay $1.69 per tablet for it, against $3.20 for this one. Only your prescriber can say whether a different strength or form suits you.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other everolimus strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.25 mg tablet | $1.69 | $50.66 / 30 tablets |
| 0.75 mg tablet | $3.87 | $116.19 / 30 tablets |
| 1 mg tablet | $5.49 | $164.57 / 30 tablets |
| 5 mg tablet | $14.77 | $443.12 / 30 tablets |
| 10 mg tablet | $26.32 | $789.73 / 30 tablets |
Official label & what changed
These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2010
WARNING: MALIGNANCIES and SERIOUS INFECTIONS; KIDNEY GRAFT THROMBOSIS; NEPHROTOXICITY; and MORTALITY IN HEART TRANSPLANTATION
WARNING: MALIGNANCIES and SERIOUS INFECTIONS; KIDNEY GRAFT THROMBOSIS; NEPHROTOXICITY; and MORTALITY IN HEART TRANSPLANTATION
See full prescribing information for complete boxed warning.
Only physicians experienced in immunosuppressive therapy and management of transplant patients should use everolimus (5.1)
Increased susceptibility to infection and the possible development of malignancies may result from immunosuppression (5.2, 5.3)
Increased incidence of kidney graft thrombosis (5.4)
Reduced doses of cyclosporine are required for use in combination with everolimus in order to reduce nephrotoxicity (2.4, 2.5, 5.6, 12.7, 12.8)
Increased mortality in a heart transplant clinical trial. Use in heart transplantation is not recommended (5.7)
Malignancies and Serious Infections
Only physicians experienced in immunosuppressive therapy and management of transplant patients should prescribe everolimus. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient [see Warnings and Precautions (5.1)].
Increased susceptibility to infection and the possible development of malignancies, such as lymphoma and skin cancer, may result from immunosuppression [see Warnings and Precautions (5.2, 5.3)].
Kidney Graft Thrombosis
An increased risk of kidney arterial and venous thrombosis, resulting in graft loss, was reported, mostly within the first 30 days posttransplantation [see Warnings and Precautions (5.4)].
Nephrotoxicity
Increased nephrotoxicity can occur with use of standard doses of cyclosporine in combination with everolimus. Therefore, reduced doses of cyclosporine should be used in combination with everolimus in order to reduce renal dysfunction. It is important to monitor the cyclosporine and everolimus whole blood trough concentrations [see Dosage and Administration (2.4, 2.5), Warnings and Precautions (5.6), Clinical Pharmacology (12.7, 12.8)].
Mortality in Heart Transplantation
Increased mortality, often associated with serious infections, within the first three months post transplantation was observed in a clinical trial of de novo heart transplant patients receiving immunosuppressive regimens with or without induction therapy. Use in heart transplantation is not recommended [see Warnings and Precautions (5.7)].
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about everolimus 0.5 mg tablet
How much does everolimus 0.5 mg tablet cost without insurance?
Pharmacies pay about $96.07 for 30 tablets ($3.20 per tablet) as of November 11, 2026. A fair cash price is about $120.98: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $120.48 including shipping.
Is my price for everolimus 0.5 mg tablet fair?
Compare it with the fair cash price of $120.98 for 30 tablets. Up to about $151.22 is fair; above $241.96 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is everolimus 0.5 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay fell 9.2%. Over a year it fell 27.2%. See the 52-week chart.
Who makes everolimus 0.5 mg tablet?
6 companies: Ascend Laboratories, LLC, Aurobindo Pharma Limited, Biocon Pharma Inc., Breckenridge Pharmaceutical, Inc., Hikma Pharmaceuticals USA Inc., Par Health USA, LLC. See every package code.
Is everolimus in shortage?
Yes - 12 products are listed as short or being discontinued. Details.
Has everolimus been recalled?
6 recalls on record, 5 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about everolimus 0.5 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.